TheraVet mandates an American consulting firm to support it in developing its growth strategy on the US market


(Boursier.com) — TheraVet , a pioneering biotechnology company in the treatment of osteoarticular diseases in companion animals, announces the recruitment of Brakke Consulting to support it in the development of its growth strategy on the American market. Brakke – www.brakkeconsulting.com – is one of the leading consultancies specializing in the veterinary sector and with solid experience in the development of companies in this sector of activity in the American market.

TheraVet has been marketing BIOCERA-VET for almost a year in the US market, the largest animal health market. Since its entry into the American market, the Company has focused on the launch of the 9 variations making up its BIOCERA-VET range; BIOCERA-VET COMBO-CLEAN being the last to have been launched in October 2023. With this in mind, the Company has put in place a two-part plan: (i) the process, development and delivery for direct sales to customers and (ii) developing the network of prescribers and awareness of products through conferences, debates, clinical studies and raising awareness among opinion leaders.

The Company’s next goals are to grow rapidly from its existing base, expand its footprint and be recognized as a major player in the U.S. orthopedics market.

TheraVet called on Brakke Consulting to help it achieve its objectives based on a three-step plan (which includes validation points at the end of each phase):
-Initially, market opportunities in the United States for the TheraVet line of veterinary products will be reassessed. To objectively measure this potential, a panel of veterinary surgeons specializing in the management of osteosarcomas and orthopedics from independent and corporate practices will be interviewed.

QuotingCounting

-Second, a new strategic and marketing plan will be developed, proposing the best go-to-market, organizational and partnership structure for TheraVet’s veterinary business. This phase will include the evaluation and modeling of go-to-market options and recommendations to help TheraVet achieve its goals.

-Finally, TheraVet activities will be intensified. To create critical mass, potential merger and acquisition options, including companies that may find TheraVet a meaningful partner, will be proposed.

This plan will be developed and implemented with the assistance of Brakke Consulting, the leading consulting firm serving the animal health, animal nutrition and veterinary industries in the US market. Its consultants are seasoned industry professionals with strong credentials in leadership, management, finance, sales, distribution, marketing, brand development, communications and market research.



Source link -87